Patents Assigned to Z FACTOR LIMITED
  • Compounds and their use for the treatment of alpha1-antitrypsin deficiency
    Patent number: 11312689
    Abstract: The invention relates to oxopyrimidinyl-methyl-benzamide derivatives, for example in a pharmaceutically acceptable salt form or crystal form, pharmaceutical compositions comprising the derivatives, and their medical use, in particular for use in the treatment of ?1-antitrypsin deficiency (A1AD or AATD).
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: April 26, 2022
    Assignee: Z FACTOR LIMITED
    Inventors: Nigel Ramsden, David John Fox, James Andrew Huntington